Durvalumab and Epacadostat for Treatment of Unresectable, Recurrent, or Metastatic Epstein-Barr Virus Positive Nasopharyngeal Cancer

Name: Durvalumab and Epacadostat for Treatment of Unresectable, Recurrent, or Metastatic Epstein-Barr Virus Positive Nasopharyngeal Cancer
License: Public Domain

Alain Algazi

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

epstein-barr virus positive, metastatic nasopharyngeal carcinoma, recurrent nasopharyngeal carcinoma, stage iii nasopharyngeal carcinoma, stage iv nasopharyngeal carcinoma, stage iva nasopharyngeal carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 279520
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.